AMOXICILLIN

AMOXICILLIN
(a-mox-i-sill'in)
Amoxil, Apo-Amoxi , Larotid, Novamoxin, Trimox, DisperMox
Classifications: antibiotic; aminopenicillin;
Therapeutic:antibiotic

Prototype: Ampicillin
Pregnancy Category: B

Availability

125 mg, 250 mg, 500 mg tablets; 250 mg, 500 mg capsules; 50 mg/mL, 125 mg/5 mL, 250 mg/5 mL powder for suspension; 200 mg, 400 mg, 600 mg dispersible tablets

Action

Broad-spectrum semisynthetic aminopenicillin and analog of ampicillin. Like other penicillins, amoxicillin inhibits the final stage of bacterial cell wall synthesis by binding to specific penicillin-binding proteins (PBPs) located inside the cell wall of rapidly multiplying bacteria. It results in bacterial cell lysis and death.

Therapeutic Effect

Active against both aerobic gram-positive and aerobic gram-negative bacteria.

Uses

Infections of ear, nose, throat, GU tract, skin, and soft tissue caused by susceptible bacteria. Also used in uncomplicated gonorrhea.

Contraindications

Hypersensitivity to penicillins; infectious mononucleosis.

Cautious Use

History of or suspected atopy or allergy (hives, eczema, hay fever, asthma); history of cephalosporin or carbapenem hypersensitivity; colitis, dialysis, diarrhea, GI disease; viral infection, syphilis, renal impairment or failure, diabetes mellitus, leukemia, pregnancy (category B); infants, neonates.

Route & Dosage

Mild to Moderate Infections
Adult: PO 250–500 mg q8h
Child: PO 25–50 mg/kg/d (max: 60–80 mg/kg/d) divided q8h or 200–400 mg q12h

Gonorrhea
Adult: PO 3 g as single dose with 1 g probenecid
Child (≥2 y): PO 50 mg/kg as single dose with probenecid 25 mg/kg

Administration

Oral
  • Ensure that chewable tablets are chewed or crushed before being swallowed with a liquid.
  • Place reconstituted pediatric drops directly on child's tongue or add to formula, milk, fruit juice, water, ginger ale, or other soft drink. Have child drink all the prepared dose promptly.
  • Store in tightly covered containers at 15°–30° C (59°–86° F) unless otherwise directed. Reconstituted oral suspensions are stable for 7 d at room temperature.

Adverse Effects (≥1%)

Body as a Whole: As with other penicillins. Hypersensitivity (rash, anaphylaxis), superinfections. GI: Diarrhea, nausea, vomiting, pseudo-membranous colitis (rare). Hematologic: Hemolytic anemia, eosinophilia, agranulocytosis (rare). Skin: Pruritus, urticaria, or other skin eruptions. Special Senses: Conjunctival ecchymosis.

Interactions

tetracyclines may inhibit activity of amoxicillin; probenecid prolongs the activity of amoxicillin.

Pharmacokinetics

Absorption: Nearly complete absorption. Peak: 1–2 h. Distribution: Diffuses into most tissues and body fluids, except synovial fluid and CSF (unless meninges are inflamed); crosses placenta; distributed into breast milk in small amounts. Metabolism: In liver. Elimination: 60% of dose in urine in 6–8 h. Half-Life: 1–1.3 h.

Nursing Implications

Assessment & Drug Effects

  • Determine previous hypersensitivity reactions to penicillins, cephalosporins, and other allergens prior to therapy.
  • Lab tests: Baseline C&S tests prior to initiation of therapy, start drug pending results; periodic assessments of renal, hepatic, and hematologic functions should be made during prolonged therapy.
  • Monitor for S&S of an urticarial rash (usually occurring within a few days after start of drug) suggestive of a hypersensitivity reaction. If it occurs, look for other signs of hypersensitivity (fever, wheezing, generalized itching, dyspnea), and report to physician immediately.
  • Report onset of generalized, erythematous, maculopapular rash (ampicillin rash) to physician. Ampicillin rash is not due to hypersensitivity; however, hypersensitivity should be ruled out.
  • Closely monitor diarrhea to rule out pseudomembranous colitis.

Patient & Family Education

  • Take drug around the clock, do not miss a dose, and continue therapy until all medication is taken, unless otherwise directed by physician.
  • Report onset of diarrhea and other possible symptoms of superinfection to physician (see Appendix F).

Common adverse effects in italic, life-threatening effects underlined; generic names in bold; classifications in SMALL CAPS; Canadian drug name; Prototype drug

(149)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.
© 2006-2025 medpill.info Last Updated On: 06/16/2025 (0)
×
Wait 20 seconds...!!!